BioCentury | Nov 21, 2016
Strategy
LG’s biotech legacy
...itself. At Nov. 18, the combined value of CrystalGenomics Inc. (KOSDAQ:083790), LegoChem BioSciences Inc. (KOSDAQ:141080), Peptron...
...three had helped to build LG’s expertise in structure-based NMR, X-ray crystallography and medicinal chemistry. Peptron...
...candidate is a sustained-release GLP-1 analog that is in Phase II testing to treat diabetes. Peptron...
...three had helped to build LG’s expertise in structure-based NMR, X-ray crystallography and medicinal chemistry. Peptron...
...candidate is a sustained-release GLP-1 analog that is in Phase II testing to treat diabetes. Peptron...
